EGRX
Eagle Pharmaceuticals, Inc.
EGRX
EGRX
Delisted
EGRX was delisted on the 2nd of October, 2024.
160 hedge funds and large institutions have $555M invested in Eagle Pharmaceuticals, Inc. in 2022 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 55 increasing their positions, 66 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
160
Holders Change
-2
Holders Change %
-1.23%
% of All Funds
2.53%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
15
Increased
55
Reduced
66
Closed
17
Calls
$24K
Puts
$485K
Net Calls
-$461K
Net Calls Change
-$1.15M
Top Buyers
| 1 |
AC
Armistice Capital
New York
|
$11.1M |
| 2 |
DZ Bank
Frankfurt Am Main,
Germany
|
$8.47M |
| 3 |
Goldman Sachs
New York
|
$8.83M |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
$4.34M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
$6.91M |
